Big Pharma is Paying Attention, But Can They Adapt to the AI-Driven Landscape?

Welcome to this special series of the Moneyball Medicine Podcast focused on Artificial Intelligence, Machine Learning and Analytics applied to Drug Discovery and Development. This special series was recorded as part of the AI Applications Summit produced by Corey Lane Partners this October (2018) in Boston, MA. In this series I have interviewed different speakers from the event and we will hear their experiences. We will dive into the challenges and opportunities they’re facing, and their predictions for the years to come.

This is part 2 of a special 6-part series. In this episode Harry talks with Milind Kamkolkar, chief data officer at Sanofi, about how big pharma can start using new data sources to uncover new insights about disease.